Pacira BioSciences
Stock Forecast, Prediction & Price Target
Pacira BioSciences (PCRX) stock Price Target by analysts
$12
Potential downside: -52.36%
Pacira BioSciences price prediction
What is Pacira BioSciences stock analysts` prediction?
Pacira BioSciences stock forecast: Based on 1 Wall Street analysts` predicted price targets for Pacira BioSciences in the last 3 months, the avarage price target is $12, with a high forecast of $NaN. The average price target represents a -52.36% change from the last price of $25.19.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Pacira BioSciences stock Price Target by analysts
Full breakdown of analysts given Pacira BioSciences price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Amsellem Piper Sandler | 0% 0/2 | 11 months ago | $12 -52.36% downside | $17.37 | StreetInsider | Previous targets (1) |
Glen Santangelo Jefferies | 0% 0/2 | about 1 year ago | $18 -28.54% downside | $14.77 | StreetInsider | Previous targets (1) |
Les Sulewski Truist Financial | 0% 0/1 | about 1 year ago | $8 -68.24% downside | $12.29 | TheFly | Previous targets (0) |
Oren Livnat H.C. Wainwright | 0% 0/1 | about 1 year ago | $57 126.28% upside | $21.91 | TheFly | Previous targets (0) |
Glen Santangelo Jefferies | 0% 0/2 | over 1 year ago | $36 42.91% upside | $28.5 | StreetInsider | Previous targets (1) |
David Amsellem Piper Sandler | 0% 0/2 | over 1 year ago | $42 66.73% upside | $30.68 | StreetInsider | Previous targets (1) |
Pacira BioSciences H.C. Wainwright | 0% 0/1 | about 2 years ago | $63 150.09% upside | $33.75 | Defense World | Previous targets (0) |
Pacira BioSciences New Street | 0% 0/1 | about 2 years ago | $68 169.94% upside | $33.75 | Defense World | Previous targets (0) |
Pacira BioSciences Truist Financial | 0% 0/1 | about 2 years ago | $55 118.34% upside | $33.75 | Defense World | Previous targets (0) |
Pacira BioSciences Needham | 0% 0/1 | about 2 years ago | $52 106.43% upside | $33.75 | Defense World | Previous targets (0) |
Unknown Needham | N/A | over 2 years ago | $63 150.09% upside | $38.5 | Benzinga | N/A |
Unknown BMO Capital | N/A | over 2 years ago | $52 106.43% upside | $38.5 | Benzinga | N/A |
Pacira BioSciences Financial Estimates
Pacira BioSciences Revenue Estimates
Pacira BioSciences EBITDA Estimates
Pacira BioSciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $541.53M N/A | $666.82M 23.13% | $674.97M 1.22% | Avg: $760.10M Low: $746.00M High: $777.19M avg. 12.61% | Avg: $831.92M Low: $816.19M High: $844.36M avg. 9.44% | Avg: $892.18M Low: $875.30M High: $905.52M avg. 7.24% | Avg: $962.28M Low: $944.08M High: $976.66M avg. 7.85% |
Net Income
% change YoY
| $41.98M N/A | $15.90M -62.10% | $41.95M 163.71% | Avg: $82.04M Low: $61.85M High: $126.82M avg. 95.55% | Avg: $115.57M Low: $82.64M High: $203.75M avg. 40.87% | Avg: $246.51M Low: $240.44M High: $251.30M avg. 113.28% | Avg: $303.03M Low: $295.58M High: $308.92M avg. 22.93% |
EBITDA
% change YoY
| $144.61M N/A | $121.46M -16.00% | $157.58M 29.72% | Avg: $144.95M Low: $142.26M High: $148.21M avg. -8.01% | Avg: $158.64M Low: $155.64M High: $161.02M avg. 9.44% | Avg: $170.13M Low: $166.92M High: $172.68M avg. 7.24% | Avg: $183.50M Low: $180.03M High: $186.25M avg. 7.85% |
EPS
% change YoY
| $0.95 N/A | $0.35 -63.15% | $0.91 160.00% | Avg: $1.91 Low: $1.19 High: $2.44 avg. 109.67% | Avg: $2.88 Low: $1.59 High: $3.92 avg. 50.81% | Avg: $4.74 Low: $4.63 High: $4.83 avg. 64.81% | Avg: $5.83 Low: $5.69 High: $5.94 avg. 22.93% |
Operating Expenses
% change YoY
| $268.44M N/A | $396.60M 47.74% | $402.63M 1.52% | Avg: $317.07M Low: $311.19M High: $324.20M avg. -21.25% | Avg: $347.03M Low: $340.46M High: $352.22M avg. 9.44% | Avg: $372.16M Low: $365.12M High: $377.73M avg. 7.24% | Avg: $401.40M Low: $393.81M High: $407.41M avg. 7.85% |
FAQ
What is Pacira BioSciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 68.16% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is 61.85M, average is 82.04M and high is 126.82M.
What is Pacira BioSciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 9.29% in 2025-2028.
We have gathered data from 8 analysts. Their low revenue estimate is $746.00M, average is $760.10M and high is $777.19M.
What is Pacira BioSciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 62.05% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is $1.19, average is $1.91 and high is $2.44.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Pacira BioSciences stock. The most successful analyst is David Amsellem.